Trademarkia Logo

Australia

AU$
LENZILUMAB
Withdrawn: Applicant request

Last updated on 11 Jun 2021

Owner Info

Humanigen, Inc.

533 Airport Boulevard Suite 400

Burlingame, California, 94010 UNITED STATES OF AMERICA,

Serial Number

2130148 filed on 21 Oct 2020

Correspondent

Griffith Hack

Level 15,

376-390 Collins St,

Melbourne, VIC, 3000 AUSTRALIA

LENZILUMAB

Classification Information


Class [001]
Chemical, biochemical and biotechnological preparations used in industry and science, including, antibodies and fragments of antibodies for use in the Read More

Class [005]
Pharmaceutical preparations and substances, including, antibodies for the treatment of cancer, Immunotherapy-related toxicity, and COVID-19

Mark Details


Serial Number

2130148

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

9 Sept 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
11th Jun 2021IP Right Withdrawn correspondence sent
11th Jun 2021General Notice Published
11th Jun 2021Status change to Withdrawn
8th Jun 2021Withdrawal of IP Right Requested
28th May 2021General Request Initiated
17th Feb 2021Adverse Report (Examination) correspondence sent
17th Feb 2021IP Right has been Examined
17th Feb 2021Revoke Acceptance
17th Feb 2021Status change to Published
10th Feb 2021General Request Initiated